Daiki Hirano

753 total citations
27 papers, 414 citations indexed

About

Daiki Hirano is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Daiki Hirano has authored 27 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Daiki Hirano's work include Gastric Cancer Management and Outcomes (13 papers), Colorectal Cancer Screening and Detection (7 papers) and Esophageal Cancer Research and Treatment (6 papers). Daiki Hirano is often cited by papers focused on Gastric Cancer Management and Outcomes (13 papers), Colorectal Cancer Screening and Detection (7 papers) and Esophageal Cancer Research and Treatment (6 papers). Daiki Hirano collaborates with scholars based in Japan. Daiki Hirano's co-authors include Kazuaki Chayama, Kyoku Sumimoto, Yuki Ninomiya, Yuzuru Tamaru, Shinji Tanaka, Nana Hayashi, Kenjiro Shigita, Koji Arihiro, Naoki Asayama and Shiro Oka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Daiki Hirano

25 papers receiving 410 citations

Peers

Countries citing papers authored by Daiki Hirano

Since Specialization

Citations

This map shows the geographic impact of Daiki Hirano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daiki Hirano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daiki Hirano more than expected).

Fields of papers citing papers by Daiki Hirano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daiki Hirano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daiki Hirano. The network helps show where Daiki Hirano may publish in the future.

Co-authorship network of co-authors of Daiki Hirano

This figure shows the co-authorship network connecting the top 25 collaborators of Daiki Hirano. A scholar is included among the top collaborators of Daiki Hirano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daiki Hirano. Daiki Hirano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MO12-6 Efficacy and safety of venetoclax and azacytidine for acute myeloid leukemia: a retrospective, single-center study 2024 ·Annals of Oncology ·Yoshiharu Yamaguchi, Daiki Hirano, R. Minami, Satoshi Hirano, Yoshinori Suzuki, Nobuhiko Imahashi, Takahiro Adachi, Hiroki Nagai, Hiroko Iida	0
2	Staurosporine and venetoclax induce the caspase-dependent proteolysis of MEF2D-fusion proteins and apoptosis in MEF2D-fusion (+) ALL cells 2020 ·Biomedicine & Pharmacotherapy ·(unknown), Fumihiko Hayakawa, Takahiko Yasuda, (unknown), Hideyuki Yamamoto, Daiki Hirano, (unknown), Seitaro Terakura, Shinobu Tsuzuki, Hitoshi Kiyoi	7
3	Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-line 2020 ·International Journal of Hematology ·(unknown), Masatoshi Sakurai, Shinichiro Okamoto, Itaru Matsumura, (unknown), Makiko Takizawa, (unknown), Daiki Hirano, (unknown), Naoki Kobayashi, Masaki Iino, Hideki Mitsui, Yuichi Ishikawa, Naoto Takahashi, Tatsuya Kawaguchi, Ritsuro Suzuki, Kazuhito Yamamoto, Masahiro Kizaki, Kazunori Ohnishi, Tomoki Naoe, Koichi Akashi	4
4	Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes 2019 ·PLoS ONE ·Daiki Hirano, Yuji Urabe, Shinji Tanaka, Koki Nakamura, Yuki Ninomiya, Ryo Yuge, Ryohei Hayashi, Shiro Oka, Yasuhiko Kitadai, Fumio Shimamoto, Koji Arihiro, Kazuaki Chayama	6
5	Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia 2018 ·PLoS ONE ·(unknown), Yuichi Ishikawa, Naomi Kawashima, (unknown), (unknown), (unknown), Daiki Hirano, (unknown), Kotaro Miyao, Yoko Ushijima, Seitaro Terakura, Tetsuya Nishida, Tadashi Matsushita, Hitoshi Kiyoi	8
6	Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activity 2018 ·Oncogene ·Daiki Hirano, Fumihiko Hayakawa, Takahiko Yasuda, (unknown), Hideyuki Yamamoto, Yuki Kojima, Takanobu Morishita, (unknown), Shinobu Tsuzuki, Hiroyuki Mano, Tomoki Naoe, Hitoshi Kiyoi	13
7	Dual Red Imaging Maintains Clear Visibility During Colorectal Endoscopic Submucosal Dissection 2018 ·Digestive Diseases and Sciences ·Hidenori Tanaka, (unknown), Shinji Tanaka, (unknown), (unknown), Ken Yamashita, Daiki Hirano, Kyoku Sumimoto, Yuzuru Tamaru, Yuki Ninomiya, Nana Hayashi, Kazuaki Chayama	19
8	Use of anticoagulants increases risk of bleeding after colorectal endoscopic submucosal dissection 2018 ·SHILAP Revista de lepidopterología ·Ken Yamashita, Shiro Oka, Shinji Tanaka, (unknown), Daiki Hirano, Kyoku Sumimoto, Takeshi Mizumoto, Yuki Ninomiya, Yuzuru Tamaru, Kenjiro Shigita, Nana Hayashi, Yoji Sanomura, Kazuaki Chayama	21
9	High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotype 2017 ·PLoS ONE ·Daisuke Koyama, Makoto Murata, Ryo Hanajiri, Shingo Okuno, (unknown), Jakrawadee Julamanee, (unknown), Daiki Hirano, Kotaro Miyao, Reona Sakemura, Tatsunori Goto, Fumihiko Hayakawa, Aika Seto, Yukiyasu Ozawa, Koichi Miyamura, Seitaro Terakura, Tetsuya Nishida, Hitoshi Kiyoi	3
10	Diagnostic performance of Japan NBI Expert Team classification for differentiation among noninvasive, superficially invasive, and deeply invasive colorectal neoplasia 2017 ·Gastrointestinal Endoscopy ·Kyoku Sumimoto, Shinji Tanaka, Kenjiro Shigita, Nana Hayashi, Daiki Hirano, Yuzuru Tamaru, Yuki Ninomiya, Shiro Oka, Koji Arihiro, Fumio Shimamoto, Masaharu Yoshihara, Kazuaki Chayama	55
11	YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphoma 2017 ·Pharmacological Research ·Yuki Kojima, Fumihiko Hayakawa, Takanobu Morishita, (unknown), (unknown), (unknown), Hideyuki Yamamoto, Daiki Hirano, (unknown), Kazuyuki Shimada, Seiji Okada, Hitoshi Kiyoi	16
12	Clinicopathologic and endoscopic features of early-stage colorectal serrated adenocarcinoma 2017 ·BMC Gastroenterology ·Daiki Hirano, Shiro Oka, Shinji Tanaka, Kyoku Sumimoto, Yuki Ninomiya, Yuzuru Tamaru, Kenjiro Shigita, Nana Hayashi, Yuji Urabe, Yasuhiko Kitadai, Fumio Shimamoto, Koji Arihiro, Kazuaki Chayama	5
13	Clinical impact of surveillance colonoscopy using magnification without diminutive polyp removal 2017 ·Digestive Endoscopy ·Yuki Ninomiya, (unknown), Shinji Tanaka, (unknown), Ken Yamashita, Kyoku Sumimoto, Daiki Hirano, Yuzuru Tamaru, Kenjiro Shigita, Nana Hayashi, Taiji Matsuo, Kazuaki Chayama	12
14	Long-term outcomes after endoscopic submucosal dissection for superficial colorectal tumors 2016 ·Gastrointestinal Endoscopy ·Kenjiro Shigita, Shiro Oka, Shinji Tanaka, Kyoku Sumimoto, Daiki Hirano, Yuzuru Tamaru, Yuki Ninomiya, Naoki Asayama, Nana Hayashi, Fumio Shimamoto, Koji Arihiro, Kazuaki Chayama	64
15	Clinical impact and characteristics of the narrow-band imaging magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team 2016 ·Gastrointestinal Endoscopy ·Kyoku Sumimoto, Shinji Tanaka, Kenjiro Shigita, Daiki Hirano, Yuzuru Tamaru, Yuki Ninomiya, Naoki Asayama, Nana Hayashi, Shiro Oka, Koji Arihiro, Masaharu Yoshihara, Kazuaki Chayama	98
16	PAX5 tyrosine phosphorylation by SYK co-operatively functions with its serine phosphorylation to cancel the PAX5-dependent repression of BLIMP1: A mechanism for antigen-triggered plasma cell differentiation 2016 ·Biochemical and Biophysical Research Communications ·Yuichiro Inagaki, Fumihiko Hayakawa, Daiki Hirano, Yuki Kojima, Takanobu Morishita, Takahiko Yasuda, Tomoki Naoe, Hitoshi Kiyoi	6
17	Clinical usefulness of a single-use splinting tube for poor endoscope operability in deep colonic endoscopic submucosal dissection 2016 ·SHILAP Revista de lepidopterología ·Naoki Asayama, Shiro Oka, Shinji Tanaka, Kyoku Sumimoto, Daiki Hirano, Yuzuru Tamaru, Yuki Ninomiya, Kenjiro Shigita, Nana Hayashi, S Nishiyama, Kazuaki Chayama	16
18	Clinical impact of dual red imaging in colorectal endoscopic submucosal dissection: a pilot study 2016 ·Therapeutic Advances in Gastroenterology ·Yuki Ninomiya, Shiro Oka, Shinji Tanaka, Daiki Hirano, Kyoku Sumimoto, Yuzuru Tamaru, Naoki Asayama, Kenjiro Shigita, S Nishiyama, Nana Hayashi, Kazuaki Chayama	24
19	[A case report of hepatocellular carcinoma with metastases to the lip, stomach, and colorectum]. 2014 ·PubMed ·(unknown), Koji Waki, Keiji Tsuji, (unknown), Daiki Hirano, Yuzuru Tamaru, Masahiro Hatooka, Shunsuke Takata, Hiroyuki Ueda, (unknown), Shigeru Kimura, Shinji Nagata, Mayumi Kaneko, Hiroshi Aikata, Kazuaki Chayama	3
20	Durable Local Disease Control and Survival in Patients with Limited-Stage Diffuse Large B-Cell Lymphoma Receiving Involved-Node Radiation Therapy Plus Short-Course R-CHOP or CHOP Chemotherapy: Involved-Node Versus Involved-Field Radiation Therapy 2012 ·Blood ·Harumi Kato, Takeshi Kodaira, Kazuhito Yamamoto, (unknown), Yasuhiro Oki, Hiroyuki Tachibana, Hirofumi Taji, (unknown), Daiki Hirano, Natsuo Tomita, Yasushi Yatabe, Shigeo Nakamura, Tomohiro Kinoshita	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact